Stock Research for STML

STML

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

STML Stock Chart & Research Data

The STML chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the STML chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


STML Due diligence Resources & Stock Charts

The STML stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View STML Detailed Price Forecast - CNN Money CNN View STML Detailed Summary - Google Finance
Yahoo View STML Detailed Summary - Yahoo! Finance Zacks View STML Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View STML Trends & Analysis - Trade-Ideas Barrons View STML Major Holders - Barrons
NASDAQ View STML Call Transcripts - NASDAQ Seeking View STML Breaking News & Analysis - Seeking Alpha
Spotlight View STML Annual Report - CompanySpotlight.com OTC Report View STML OTC Short Report - OTCShortReport.com
TradeKing View STML Fundamentals - TradeKing Charts View STML SEC Filings - Bar Chart
WSJ View Historical Prices for STML - The WSJ Morningstar View Performance/Total Return for STML - Morningstar
MarketWatch View the Analyst Estimates for STML - MarketWatch CNBC View the Earnings History for STML - CNBC
StockMarketWatch View the STML Earnings - StockMarketWatch MacroAxis View STML Buy or Sell Recommendations - MacroAxis
Bullish View the STML Bullish Patterns - American Bulls Short Pains View STML Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View STML Stock Mentions - StockTwits PennyStocks View STML Stock Mentions - PennyStockTweets
Twitter View STML Stock Mentions - Twitter Invest Hub View STML Investment Forum News - Investor Hub
Yahoo View STML Stock Mentions - Yahoo! Message Board Seeking Alpha View STML Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for STML - SECform4.com Insider Cow View Insider Transactions for STML - Insider Cow
CNBC View STML Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for STML - OTC Markets
Yahoo View Insider Transactions for STML - Yahoo! Finance NASDAQ View Institutional Holdings for STML - NASDAQ


Stock Charts

FinViz View STML Stock Insight & Charts - FinViz.com StockCharts View STML Investment Charts - StockCharts.com
BarChart View STML Stock Overview & Charts - BarChart Trading View View STML User Generated Charts - Trading View


Latest Financial News for STML

Stemline Therapeutics Announces Three SL-401 Clinical Presentations, Including an Oral Presentation, at the Upcoming EHA Congress
Posted on Friday May 18, 2018

NEW YORK, May 18, 2018-- Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that SL-401 will be the subject of three clinical ...


Stemline Therapeutics Announces Presentation of SL-801 and SL-701 Clinical Data at the Upcoming ASCO Annual Meeting
Posted on Thursday May 17, 2018

NEW YORK, May 17, 2018-- Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that clinical data from SL-801 and SL-701 trials ...


Stemline Therapeutics: 1Q Earnings Snapshot
Posted on Wednesday May 09, 2018

On a per-share basis, the New York-based company said it had a loss of 69 cents. The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...


Stemline Therapeutics Reports First Quarter 2018 Financial Results
Posted on Wednesday May 09, 2018

NEW YORK, May 09, 2018-- Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today financial results for the quarter ended March 31, ...


Enter a stock symbol to view the stock details.